Getting more sleep is usually treated as an easy health win. But new research suggests that regularly sleeping more than eight and a half hours a night is linked to higher blood levels of a protein associated with Alzheimer’s disease. The rise was strongest among people reporting more than 10 hours.
The finding comes from 2,410 participants whose average age was 70. It does not show that long sleep causes Alzheimer’s. Instead, an unusually long sleep schedule may be an early behavioral signal worth checking rather than proof of disease.
What the study found
Vanessa M. Young, a postdoctoral researcher at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, led the work at UT Health San Antonio, the academic health center of The University of Texas at San Antonio.
The team used data from the Framingham Heart Study, directed by the National Heart, Lung, and Blood Institute at the National Institutes of Health. Just over 55 percent of the participants were women.
Researchers compared self-reported sleep time with four proteins measured in blood. The clearest pattern involved phosphorylated tau 181, usually shortened to p-tau181. Its levels began rising around eight and a half to nine hours of sleep and increased more sharply beyond 10 hours.
What the protein means
Tau is a protein that helps support the internal transport system of healthy nerve cells. In Alzheimer’s disease, abnormal chemical changes can make tau detach, clump together, and form tangles inside the brain. P-tau181 is one altered form that can now be measured with a blood test.
That makes p-tau181 useful as a biomarker, a measurable clue that may reflect disease-related biology. It is not the same as an Alzheimer’s diagnosis, and a single blood result cannot explain why someone sleeps longer. Think of it as a warning light, not a verdict.
An illustration represents the connection between sleep and brain health as researchers examine long sleep and Alzheimer’s-related biomarkers.
Why the curve matters
The team did not assume that each extra hour of sleep would have the same effect. Instead, it used a curved statistical model that can spot changes at different points along the sleep range. The lowest p-tau181 levels appeared around seven to eight hours, followed by a climb near eight and a half hours.
When researchers sorted people into broad short, average, and long sleep groups, the adjusted differences were not significant. The curved analysis revealed what those boxes could hide. In plain English, the data bent rather than moving in a straight line.
Other factors were tested
The association remained after the researchers accounted for age, sex, sleep apnea, depression, kidney function, and a common genetic variant tied to late-onset Alzheimer’s. That matters because several of those factors can affect both sleep and blood protein levels. Even so, statistical adjustment cannot remove every possible explanation.
The other three proteins told a different story. Their links with sleep weakened or disappeared once kidney function was considered, while p-tau181 remained associated with longer sleep. That pattern hints at an Alzheimer’s-related process, but the authors say it still needs prospective validation.
A signal, not a cause
What comes first, the longer sleep or the biological change? This study cannot answer because it captured sleep and blood markers at one point in time. Participants also estimated their own sleep instead of wearing a device that measured it.
Young stressed that the results do not prove cause and effect, adding that “more sleep is not always better for brain health.” Long sleep might reflect an early brain change, poor sleep quality, or another health issue. For now, those are possibilities, not conclusions.
Earlier research adds context
The new study builds on a 2025 analysis of 1,853 dementia- and stroke-free Framingham participants. In that work, sleeping at least nine hours was associated with poorer overall thinking, memory, visual-spatial skills, and executive function. The association was stronger in people with depressive symptoms.
A separate systematic review examined 20 studies involving 12,445 people and found that the evidence was mixed. Short sleep showed some recurring links with unfavorable Alzheimer’s fluid markers, while results for long sleep varied from study to study. That uncertainty is exactly why a long-term follow-up is needed.
Why this matters now
About 57 million people worldwide were living with dementia in 2021, according to the World Health Organization. Alzheimer’s disease may account for 60 to 70 percent of cases. Finding simple, low-cost clues before serious symptoms appear is therefore a major research priority.
Blood biomarkers are helping scientists study brain changes without relying only on expensive scans or spinal fluid tests. A sleep pattern recorded at home could eventually add useful context, but it should not be treated as a home diagnosis. The science is promising, not settled.
What sleepers should do
For adults age 65 and older, the Centers for Disease Control and Prevention recommends about seven to eight hours of sleep a day. Needs still vary, and more than nine hours is not automatically harmful, especially during illness or recovery from lost sleep. One lazy Sunday is not what this study examined.
The practical takeaway is not to cut sleep on purpose. Regularly needing nine to 10 hours or more may be worth discussing with a clinician, particularly when sleep feels unrefreshing or thinking has changed.
The full study was published in Alzheimer’s & Dementia, the Journal of the Alzheimer’s Association.
